February 19, 2019


LAGUNA HILLS, CA – Insight Medical Systems, Inc. conducted its first cadaveric evaluation of
ARVIS™, its Augmented Reality Visualization and Information System. At this pioneering event, each
surgeon was able to successfully achieve three landmark goals by navigating a distal femoral and
tibial resection in a knee procedure, navigating an acetabular cup position in a hip procedure
according to their preferred approach, and measuring leg length and joint offset.

To create this immersive augmented-reality visualization and navigated execution system, ARVIS™
combines tracking cameras with both a 3D display and handsfree interface in a standalone surgical
headset. The system, which includes a single tray of trackable instruments, provides the surgeon
with key data without the need for imaging or external equipment, as is seen in the traditional
medical technologies of computer navigation and robotics. ARVIS™ is worn and controlled by the
surgeon, tracks from the surgeon’s viewpoint, and delivers information to the surgeon right at the
point of care.

After the lab, Michael Alexiades, M.D. stated, “The cadaver lab for both hip and knee replacement
has shown me ARVIS™ is intuitive and natural to use, and highlights that the potential of this
technology is not for the far future, but is ready to implement now.”

“The lab was a great success and we are pleased to have reached this important milestone,” said
Nick van der Walt, Insight’s founder and CEO. “It was exciting to see ARVIS™ working in a surgical
environment for the first time. We’re looking forward to completing the development of the
product and obtaining FDA clearance.”

Insight Medical Systems will be exhibiting at this year’s AAOS Annual Meeting in Las Vegas, March
13-15 at booth #6534.

Please visit for more information regarding Insight Medical Systems.


About Insight Medical Systems
Insight Medical Systems is a medical device company with a focus on orthopedic surgical
procedures including spinal fusion, joint replacement and ACL reconstruction. It is leveraging augmented
reality technology to provide a highly cost effective and easy-to-use alternative to surgical navigation
systems and robots. The addressable market in the USA for computer assisted surgery in orthopedics is
estimated to reach $1 Billion by 2021.

The device referenced in this statement is not cleared by the FDA for distribution in the USA.

Media Contacts:
Jonathan Nielsen
VP of R&D